Coevolution of Resistance Against Antimicrobial Peptides

Microb Drug Resist. 2020 Aug;26(8):880-899. doi: 10.1089/mdr.2019.0291. Epub 2020 Mar 2.

Abstract

Antimicrobial peptides (AMPs) are produced by all forms of life, ranging from eukaryotes to prokaryotes, and they are a crucial component of innate immunity, involved in clearing infection by inhibiting pathogen colonization. In the recent past, AMPs received high attention due to the increase of extensive antibiotic resistance by these pathogens. AMPs exhibit a diverse spectrum of activity against bacteria, fungi, parasites, and various types of cancer. AMPs are active against various bacterial pathogens that cause disease in animals and plants. However, because of the coevolution of host and pathogen interaction, bacteria have developed the mechanisms to sense and exhibit an adaptive response against AMPs. These resistance mechanisms are playing an important role in bacterial virulence within the host. Here, we have discussed the different resistance mechanisms used by gram-positive and gram-negative bacteria to sense and combat AMP actions. Understanding the mechanism of AMP resistance may provide directions toward the development of novel therapeutic strategies to control multidrug-resistant pathogens.

Keywords: antimicrobial peptides; coevolution; gram-negative bacteria; gram-positive bacteria; resistance.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Biofilms / drug effects
  • Cell Membrane / metabolism
  • Cell Wall / drug effects
  • Cell Wall / metabolism
  • Drug Resistance, Multiple, Bacterial / drug effects
  • Drug Resistance, Multiple, Bacterial / physiology*
  • Gram-Negative Bacteria / drug effects
  • Gram-Negative Bacteria / metabolism*
  • Gram-Positive Bacteria / drug effects
  • Gram-Positive Bacteria / metabolism*
  • Microbial Sensitivity Tests
  • Peptidoglycan / metabolism
  • Pore Forming Cytotoxic Proteins / metabolism*

Substances

  • Anti-Bacterial Agents
  • Peptidoglycan
  • Pore Forming Cytotoxic Proteins